Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-07

Clinical Trial Update: Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer

View source ↗

Summary

This entry reports on an ongoing clinical trial evaluating the impact of adjuvant FOLFOX on quality of life and sensory neurotoxicity in patients with advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Folinic acid (Leucovorin) (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Stomach Neoplasms | Status: UNKNOWN